Trending News
News
News
Risk of Deadly Skin Cancer May Be Gauged by Accumulated DNA Damage
Risk for melanoma, the most deadly skin cancer, can be estimated long before detection of any suspicious moles, according to a UC San Francisco scientist who led a new study to detect DNA mutations in individual skin cells.
News
Changing the Course of Early Cancer Detection To Save More Lives
Earlier detection of cancer offers arguably the single biggest opportunity to save lives from the disease. The authors of this roadmap hope that the prioritisation of early detection and diagnosis of cancer by scientists, companies, health services and government will create a thriving multidisciplinary ecosystem, focussed on proactively managing patients’ health and wellbeing before symptoms arise.
News
Diagnosing COVID-19 in Just 30 Minutes
A joint research team comprised of Professor Jeong Wook Lee and Ph.D. candidate Chang Ha Woo and Professor Gyoo Yeol Jung and Dr. Sungho Jang have together developed a SENSR (SENsitive Splint-based one-pot isothermal RNA detection) technology that allows anyone to easily and quickly diagnose COVID-19 based on the RNA sequence of the virus.
News
Dried Blood Spot Sampling Offers an Inexpensive Way To Widen Access to Antibody Testing for COVID-19
Using dried blood spot samples (DBS) is an accurate alternative to venous blood in detecting SARS-CoV-2 antibody tests, a new study by immunology experts at the University of Birmingham has found.
News
Promising Breath Test for Head and Neck Cancer in Development
Flinders University researchers have reported significant progress in developing a method to test exhaled breath profiles which accurately differentiate head and neck cancer from non-cancer patients.
News
OncoHost Data on Host Immunotherapy Response to be Presented This Week
OncoHost, announced that Professor Yuval Shaked, Professor of Cell Biology and Cancer Science at the Technion – Israel Institute of Technology, will deliver a presentation titled A Proteomics-Based Platform for Predicting Response to Immunotherapy and Personalizing Treatment Plans at the MAP 2020 Virtual Congress.
News
PerkinElmer Announces CE-IVD Approval of EONIS™ Newborn Screening Assay
PerkinElmer announced that the Company’s EONIS™ screening assay for newborns has received CE-IVD approval. The design of the EONIS assay enables automation with JANUS Liquid Handlers to further streamline the workflow of high-throughput laboratories without compromising the sample traceability from punch to result.
News
Low-Cost Sensor Can Rapidly Detect COVID-19 Infection
Caltech researchers have developed a new type of multiplexed test with a low-cost sensor that may enable the at-home diagnosis of a COVID infection through rapid analysis of small volumes of saliva or blood, without the involvement of a medical professional, in less than 10 minutes.
News
Chelation Partners’ Anti-infective Polymer Improves Survival in Bacterial Sepsis
Chelation Partners announced on 1st October the publication of positive preclinical results in an experimental animal model of fatal bacterial sepsis. An independent research group led by Christian Lehmann, MD, of Dalhousie University in Halifax, Nova Scotia, conducted the research. Dr. Lehmann concluded that "DIBI has promising potential for sepsis treatment including its use as a sole or an adjunct therapeutic with antibiotics".
News
Dutch Vico Therapeutics Appoints Rupert Sandbrink and Anders Hinsby as CMO and Independent Director
Vico Therapeutics, a biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, announced the appointment of Rupert Sandbrink, M.D., Ph.D., as the company’s chief medical officer and Anders Hinsby, Ph.D., as independent Director on the 1st October.
Advertisement